| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/08/2002 | WO2002060948A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/08/2002 | WO2002060943A1 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 08/08/2002 | WO2002060942A2 Protein modification and maintenance molecules |
| 08/08/2002 | WO2002060940A1 Juvenile hormone esterase |
| 08/08/2002 | WO2002060932A2 A serpin in bifidobacteria |
| 08/08/2002 | WO2002060931A2 A fimbria-like gene in bifidobacteria |
| 08/08/2002 | WO2002060930A2 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
| 08/08/2002 | WO2002060928A2 Medane genes and proteins |
| 08/08/2002 | WO2002060924A2 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds |
| 08/08/2002 | WO2002060919A2 Molecules with extended half-lives, compositions and uses thereof |
| 08/08/2002 | WO2002060662A2 System for and method of performing evaluation techniques on a log or round timber |
| 08/08/2002 | WO2002060657A1 Slicing machine having an apparatus for setting the size o an image processor window |
| 08/08/2002 | WO2002060656A1 Method and apparatus for setting the size of a image processor window in a slicing machine |
| 08/08/2002 | WO2002060584A2 Method for carrying out a biochemical protocol in continuous flow in a microreactor |
| 08/08/2002 | WO2002060575A2 Well-based biosensor for detecting molecular or cellular events |
| 08/08/2002 | WO2002060471A2 Ligands for receptor-like protein tyrosine phosphatases |
| 08/08/2002 | WO2002060470A1 Pyk2 phosphorylation by her3 induces tumor invasion |
| 08/08/2002 | WO2002060469A1 Anticancer agents |
| 08/08/2002 | WO2002060464A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use |
| 08/08/2002 | WO2002060420A2 Utilization of a claudin-4 ligand and conjugates thereof in the therapy and diagnosis of tumors |
| 08/08/2002 | WO2002060377A2 The separation, identification and quantitation of protein mixtures |
| 08/08/2002 | WO2002060340A2 Method for identifying maxi-k channel blockers |
| 08/08/2002 | WO2002060318A2 Detection of methylated cpg rich sequences diagnostic for malignant cells |
| 08/08/2002 | WO2002056018A8 Surface chemical modification of optical elements |
| 08/08/2002 | WO2002052275A3 Method for identifying blood cell hemostasis |
| 08/08/2002 | WO2002048686A3 Method for detecting a gas using an infrared gas analyzer and gas analyzer suitable for carrying out said method |
| 08/08/2002 | WO2002043828A3 Microtiter plate format device and methods for separating differently charged molecules using an electric field |
| 08/08/2002 | WO2002039883A3 Method for differentiating between irritable bowel syndrome and inflammatory bowel disease using lactoferrin as marker |
| 08/08/2002 | WO2002037111A3 Continuous-flow homogeneous biochemical assays based on mass spectrometric detection of known ligands |
| 08/08/2002 | WO2002034945A3 Estrogen receptor alpha variants and methods of detection thereof |
| 08/08/2002 | WO2002033403A3 Filtration container |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2002031500A3 Method for diagnosing or classifying carcinomas, based on the detection of igf-ir$g(b) and irs-1 |
| 08/08/2002 | WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 08/08/2002 | WO2002022161A3 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 08/08/2002 | WO2002020833A3 Method for the specific determination of dna -sequences by means of parallel amplification |
| 08/08/2002 | WO2002020762A3 Tnf receptor-like molecules and uses thereof |
| 08/08/2002 | WO2002020740A3 Proteolysis targeting chimeric pharmaceutical |
| 08/08/2002 | WO2002018432A3 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 08/08/2002 | WO2002015722A3 Treatment of helicobacter with isothiocyanates |
| 08/08/2002 | WO2002010707A3 System and method for monitoring water using bivalve mollusks |
| 08/08/2002 | WO2002008450A3 Method for measuring jnk/sapk activity by phosphorylation of transcription factors |
| 08/08/2002 | WO2002002807A3 Diagnosis of diseases associated with cell signalling |
| 08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 08/08/2002 | WO2002000840A3 Human lyases |
| 08/08/2002 | WO2001096546A3 Protein phosphatases |
| 08/08/2002 | WO2001096528A3 Human tumor necrosis factor delta and epsilon |
| 08/08/2002 | WO2001094635A9 Integrated active flux microfluidic devices and methods |
| 08/08/2002 | WO2001092883A3 Surface for the immobilisation of ligands |
| 08/08/2002 | WO2001091786A3 Diagnosis and treatment of herpes infections |
| 08/08/2002 | WO2001090330A3 AMINOACYL tRNA SYNTHETASES |
| 08/08/2002 | WO2001088101A3 CELL LINE FOR THE EXPRESSION OF AN α2δ2 CALCIUM CHANNEL SUBUNIT |
| 08/08/2002 | WO2001087935A3 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg) |
| 08/08/2002 | WO2001085784A9 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF |
| 08/08/2002 | WO2001085664A3 Compounds and methods for regulating bacterial growth and pathogenesis |
| 08/08/2002 | WO2001080890A3 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype |
| 08/08/2002 | WO2001077376A3 Diagnosis of diseases associated with metastasis |
| 08/08/2002 | WO2001076451A9 Diagnosis of diseases associated with metabolism |
| 08/08/2002 | WO2001075435A3 Fluorescence assay for gamma-secretase activity and inhibitors |
| 08/08/2002 | WO2001075171A3 Methods, compositions and kits for the detection and monitoring of breast cancer |
| 08/08/2002 | WO2001059152A9 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 08/08/2002 | WO2001059151A3 Method of designing and selecting polynucleotide sequences |
| 08/08/2002 | WO2001053834A3 Detection of pathological defects in cells |
| 08/08/2002 | WO2001048238A3 Chemotherapeutant screening method |
| 08/08/2002 | WO2001046477A9 Multispecies food testing and characterization |
| 08/08/2002 | WO2001034802A9 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 08/08/2002 | WO2001032925A9 Modulation of neuroendocrine differentiation by protein 25.1 |
| 08/08/2002 | WO2001031566A9 Apparatus and methods for verifying the location of areas of interest within a sample in an imaging system |
| 08/08/2002 | WO2001031011A9 Gene mining system and method |
| 08/08/2002 | WO2001028512A9 Selective removal of contaminants from a surface using articles having magnets |
| 08/08/2002 | WO2001027635A9 Multiwell scanner and scanning method |
| 08/08/2002 | WO2001025473A9 Systems and methods for characterizing a biological condition or agent using calibrated gene expression profiles |
| 08/08/2002 | WO2001021799A9 Traf4 associated cell cycle proteins, compositions and methods of use |
| 08/08/2002 | WO2001011374A3 An automated point of care detection system including complete sample processing capabilities |
| 08/08/2002 | WO2001009328A9 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 08/08/2002 | WO2001009325A9 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 08/08/2002 | WO2000049385A3 Method and apparatus for analyzing cells in a whole blood sample |
| 08/08/2002 | WO2000048703A9 Purification of biological substances |
| 08/08/2002 | US20020107643 Process for pan-genomic determination of macromolecular atomic structures |
| 08/08/2002 | US20020107640 Methods for determining the true signal of an analyte |
| 08/08/2002 | US20020107411 Such as 25-hydroxy-3-aminopropoxyvitamin D3 biotinamide; kits |
| 08/08/2002 | US20020107385 Human breast tumor-specific proteins |
| 08/08/2002 | US20020107372 Nucleotide sequences coding membrane protein for use in the treatment of inflammation,lung defects and viral diseases |
| 08/08/2002 | US20020107370 Protein for use in the treatment of lzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, retinopathy, brain, blood, myocardium, stroke, reperfusion injury and liver disorders |
| 08/08/2002 | US20020107368 Helicobacter proteins, gene sequences and uses thereof |
| 08/08/2002 | US20020107362 Novel fluorescent proteins |
| 08/08/2002 | US20020107361 Novel metalloproteases having thrombospondin domains and nucleic acid compositions encoding the same |
| 08/08/2002 | US20020107360 Hepatitis E virus antigens and uses therefor |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107233 Useful for treating hypocholesterolemia |
| 08/08/2002 | US20020107226 Assays and reagents for identifying anti-fungal agnets, amd uses related thereto |
| 08/08/2002 | US20020107215 Nucleic acids and proteins that are markers for specific normal or cancerous tissues; use in diagnosis of cancer; gene expression using specified tissue-specific promoters |
| 08/08/2002 | US20020107186 Isolated NOVX polynucleotides and polypeptides encoded by them |
| 08/08/2002 | US20020107180 Cell surface glycoproteins |
| 08/08/2002 | US20020107179 By using a fluorochrome labeles lectin to bind to chitinous contaminants such as insect parts |
| 08/08/2002 | US20020107177 And methods for identifying Factor XIIIa inhibitors by contacting chemical in question with lipoprotein(a) component, a matrix component, and Factor XIIIa; complex formation inhibition indicates activity |
| 08/08/2002 | US20020107173 Method of treating amyloid beta precursor disorders |
| 08/08/2002 | US20020106827 Infrared thermographic screening technique for semiconductor-based chemical sensors |
| 08/08/2002 | US20020106808 Accurately monitoring lipid peroxidation in body fluids; obtain sample, insert into container, insert into aparatus, sublimate at reduced pressure, heat, measure signal, evaluate lipid peroxidation |
| 08/08/2002 | US20020106807 Composition and method for detecting an adulterant in an aqueous sample |